Mitsunobu Otsuru, Nobuhiro Yamakawa, Tadaaki Kirita, Shin-ichi Yamada, Hiroshi Kurita, Takuma Kugimoto, . . . Tomohiro Yamada. (2024). Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan. Elsevier.
Chicago Style (17th ed.) CitationMitsunobu Otsuru, et al. Efficacy and Safety of Molecularly Targeted Agents and Immune Checkpoint Inhibitors for Unresectable or Recurrent/metastatic Oral Cancer in Japan. Elsevier, 2024.
MLA (9th ed.) CitationMitsunobu Otsuru, et al. Efficacy and Safety of Molecularly Targeted Agents and Immune Checkpoint Inhibitors for Unresectable or Recurrent/metastatic Oral Cancer in Japan. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.